Expert Interview

This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

Examining the potential of STRO-002, Sutro's FolRα-targeting ADC in treating ovarian cancer

Ticker(s): STRO

Who's the expert?

Institution: Massachusetts General Hospital

Professor of Obstetrics, Gynecology and Reproductive Biology at Harvard Medical School & Chief Medical Officer of the Massachusetts General Physicians Organization.
Currently manages 450 patients with ovarian cancer and has experience prescribing ADC's
PI of clinical trials evaluating novel therapies in the treatment of ovarian cancer, as well as the design of a novel device for delivery of intra-peritoneal catheter.

Interview Goal

This conversation will focus therapies in development for ovarian cancer with a focus on STRO-002, a folate receptor alpha (FolRα)-targeting antibody-drug conjugate (ADC) currently in development by Sutro Biopharma.

Are You Interested In These Questions?

Yes! Sign me up for FREE
so I can learn more Yes.
LOGIN!

Click Here to Access
This Project

Slingshot Insights Explained

JOIN FOR FREE TODAY

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

Click Here to Access
This Project

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.